Sign inJoin waitlistJoin the waitlist

Manish Patel

Physician · Sarasota Memorial Hospital

Credentials: · · · · ·

History

Sarasota Memorial Hospital
Present

Hematology and Medical Oncology
University of South Florida Morsani College of Medicine
2008–2011
Internal Medicine
2005–2008
Univ of Miami Leonard M. Miller Sch of Med
2001–2005

Research

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Blood · 2017 · 1,232 citations
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
Cancer Discovery · 2017 · 648 citations
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Journal of Clinical Oncology · 2017 · 485 citations

JI
Jeffrey Infante
19 papers
EH
Erika Hamilton
17 papers
JB
Johanna Bendell
17 papers
TB
Todd Bauer
17 papers
IF
Ian Flinn
16 papers
HB
Howard Burris
15 papers
GF
Gerald Falchook
14 papers
Shubham Pant
14 papers
Kathleen Moore
10 papers
Patricia LoRusso
9 papers
DT
Donald Tsai
8 papers
James Gulley
8 papers

Clinical trials

Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma
Principal investigator · Completed · Phase 1
Avalo Therapeutics, Inc.
2020–2022
Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma
Principal investigator · Active not recruiting · Phase 2
Manish Patel
2019–2026
Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours
Principal investigator · Completed · Phase 1
AstraZeneca
2015–2026
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Site PI · Recruiting · Phase 4
Eli Lilly and Company
2025–2032